Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Pharmacology & Therapeutics
|
April 28, 2026
The aftermath of alcohol misuse: Linking cellular damage, suboptimal micronutrient nutrition, and organ dysfunction
Janos Paloczi, Lauri O Byerley, Stefany D Primeaux
Antioxidants & Redox Signaling
|
May 13, 2017
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
Janos Paloczi, Zoltan V Varga, George Hasko, et al.
Alcohol Research : Current Reviews
|
October 10, 2017
Alcohol Misuse and Kidney Injury: Epidemiological Evidence and Potential Mechanisms
Zoltan V Varga, Csaba Matyas, Janos Paloczi, et al.
Scientific Reports
|
August 27, 2017
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
Vanessa Petrucci, Andrea Chicca, Sandra Glasmacher, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Concurrent Chronic-Plus-Binge Alcohol Consumption and Nicotine Vaping Alter the Cardiac Ventricular Proteome in a Preclinical Mouse Model
Nicholas R Harris, Eden M Gallegos, Meagan Donovan, et al.
Cells
|
December 22, 2023
Abstinence Restores Cardiac Function in Mice with Established Alcohol-Induced Cardiomyopathy
Joshua M Edavettal, Nicholas R Harris, Sarah E Cohen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 27, 2025
Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use
Janos Paloczi, Ozge Gunduz-Cinar, Burhan Yokus, et al.
JACC. Basic to Translational Science
|
November 27, 2019
Alcohol Binge-Induced Cardiovascular Dysfunction Involves Endocannabinoid-CB1-R Signaling
Janos Paloczi, Csaba Matyas, Resat Cinar, et al.
Free Radical Biology & Medicine
|
November 27, 2019
Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome
Eszter Trojnar, Katalin Erdelyi, Csaba Matyas, et al.
Geroscience
|
April 23, 2022
Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis
Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Pharmacology & Therapeutics
|
April 28, 2026
The aftermath of alcohol misuse: Linking cellular damage, suboptimal micronutrient nutrition, and organ dysfunction
Janos Paloczi, Lauri O Byerley, Stefany D Primeaux
Antioxidants & Redox Signaling
|
May 13, 2017
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
Janos Paloczi, Zoltan V Varga, George Hasko, et al.
Alcohol Research : Current Reviews
|
October 10, 2017
Alcohol Misuse and Kidney Injury: Epidemiological Evidence and Potential Mechanisms
Zoltan V Varga, Csaba Matyas, Janos Paloczi, et al.
Scientific Reports
|
August 27, 2017
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
Vanessa Petrucci, Andrea Chicca, Sandra Glasmacher, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Concurrent Chronic-Plus-Binge Alcohol Consumption and Nicotine Vaping Alter the Cardiac Ventricular Proteome in a Preclinical Mouse Model
Nicholas R Harris, Eden M Gallegos, Meagan Donovan, et al.
Cells
|
December 22, 2023
Abstinence Restores Cardiac Function in Mice with Established Alcohol-Induced Cardiomyopathy
Joshua M Edavettal, Nicholas R Harris, Sarah E Cohen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 27, 2025
Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use
Janos Paloczi, Ozge Gunduz-Cinar, Burhan Yokus, et al.
JACC. Basic to Translational Science
|
November 27, 2019
Alcohol Binge-Induced Cardiovascular Dysfunction Involves Endocannabinoid-CB1-R Signaling
Janos Paloczi, Csaba Matyas, Resat Cinar, et al.
Free Radical Biology & Medicine
|
November 27, 2019
Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome
Eszter Trojnar, Katalin Erdelyi, Csaba Matyas, et al.
Geroscience
|
April 23, 2022
Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis
Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai, et al.
Page
of 3